Cumberland Pharmaceuticals Inc CPIX
π Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2009-08-11 |
| Shares Out. | 14,980,000 |
| Website | cumberlandpharma.com/ β |
| Phone | 18774842700 |
| Employees | 93 |
| Revenue | $9.1M |
| Gross Profit | $7.2M |
| Net Income | -$3.3M |
| Free Cash Flow | $1.4M |
| Total Assets | $71.0M |
| Total Liabilities | $49.7M |
| Equity | $21.3M |
About Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Cumberland Pharmaceuticals Inc is a publicly traded company under the ticker symbol CPIX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
6 analysts (2026-07-01)

